New lupus drug enters first human tests – safety first
NCT ID NCT05835986
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 19 times
Summary
This study tests an experimental drug called RO7507062 in 70 people with systemic lupus erythematosus (SLE). The main goal is to check safety and how the drug moves through the body, not to cure the disease. Participants will receive the drug as a shot under the skin, and the study will look for side effects and find the right dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CREA Hospital Mexico Americano
RECRUITINGGuadalajara, Jalisco, 44620, Mexico
-
Centre For Human Drug Research
COMPLETEDLeiden, 2333, Netherlands
-
Chang Gung Medical Foundation - Linkou
RECRUITINGTaoyuan, 333, Taiwan
-
Charité Research Organisation GmbH
RECRUITINGBerlin, 10117, Germany
-
Chung Shan Medical University Hospital
RECRUITINGTaichung, 40201, Taiwan
-
Clinica De La Costa
RECRUITINGBarranquilla, 080020, Colombia
-
Clínica San Juan Bautista CSJB
RECRUITINGLima, 15431, Peru
-
FARMOVS (Pty) Ltd
RECRUITINGBloemfontein, 9301, South Africa
-
Groupe Hospitalier Pitie-Salpetriere
RECRUITINGParis, 75651, France
-
Hospital Angeles De Lindavista
RECRUITINGMexico City, Mexico CITY (federal District), 07760, Mexico
-
Hospital General De Mexico
RECRUITINGMexico City, Mexico CITY (federal District), 6726, Mexico
-
Hospital General Universitario Gregorio Marañon
RECRUITINGMadrid, 28007, Spain
-
Hospital Pablo Tobon Uribe
RECRUITINGMedellín, 050034, Colombia
-
Hospital Umum Sarawak
RECRUITINGKuching, 93586, Malaysia
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, 28041, Spain
-
Hospital Universitario Reina Sofia
RECRUITINGCórdoba, 14004, Spain
-
Hôpital Saint Eloi
RECRUITINGMontpellier, 34295, France
-
MICS Centrum Medyczne Damiana, Walbrzyska
WITHDRAWNWarsaw, 02-739, Poland
-
Oncomedica S.A.
RECRUITINGMontería, 230002, Colombia
-
Ramathibodi Hospital, Mahidol Uni
RECRUITINGBangkok, 10400, Thailand
-
UCL Hospital NHS Trust
RECRUITINGLondon, NW1 2PG, United Kingdom
-
Universitätsklinikum Duesseldorf
RECRUITINGDüsseldorf, 40225, Germany
-
Uniwersytecki Szpital Kliniczny w Poznaniu
RECRUITINGPóźna, 61-848, Poland
-
Wojskowy Instytut Medyczny- Panstwowy Instytut Badawczy
RECRUITINGWarsaw, 04-141, Poland
Conditions
Explore the condition pages connected to this study.